CF
THRD

Cantor Fitzgerald’s Third Harmonic Bio THRD Stock Holding History

Cantor Fitzgerald’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-86,325
Closed -$464K – 367
2025
Q3 		$464K Buy
+86,325
New +$469K ﹤0.01% 301

Other funds holding THRD

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Cantor Fitzgerald's THRD Position: Q4 2025 in Review

Cantor Fitzgerald sold out of Third Harmonic Bio (THRD) in Q4 2025, closing a stake of 86,325 shares — an estimated $464K sold.

Cantor Fitzgerald first reported a position in THRD in Q3 2025 and held it in 1 quarter. The position peaked at $464K in Q3 2025. 4 funds tracked by Wall St. Rank hold THRD as of Q4 2025.

  • Cantor Fitzgerald reported no remaining Third Harmonic Bio position as of Q4 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 86,325 Third Harmonic Bio shares in Q4 2025, an estimated $464K.
  • Cantor Fitzgerald first reported a position in Third Harmonic Bio in Q3 2025 and held it in 1 quarter.
  • Cantor Fitzgerald's Third Harmonic Bio position peaked at $464K in Q3 2025.
  • 4 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q4 2025.

Based on Cantor Fitzgerald's 13F filing for Q4 2025, filed 17 Feb 2026.